Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Change in Inventory (2023 - 2025)

Lexicon Pharmaceuticals (LXRX) has disclosed Change in Inventory for 3 consecutive years, with $123000.0 as the latest value for Q4 2025.

  • Quarterly Change in Inventory rose 130.37% to $123000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $50000.0 through Dec 2025, up 133.33% year-over-year, with the annual reading at $50000.0 for FY2025, 133.33% up from the prior year.
  • Change in Inventory for Q4 2025 was $123000.0 at Lexicon Pharmaceuticals, up from -$10000.0 in the prior quarter.
  • The five-year high for Change in Inventory was $172000.0 in Q2 2023, with the low at -$405000.0 in Q4 2024.
  • Average Change in Inventory over 3 years is $25545.5, with a median of $51000.0 recorded in 2024.
  • The sharpest move saw Change in Inventory tumbled 1000.0% in 2024, then surged 130.37% in 2025.
  • Over 3 years, Change in Inventory stood at $45000.0 in 2023, then crashed by 1000.0% to -$405000.0 in 2024, then soared by 130.37% to $123000.0 in 2025.
  • According to Business Quant data, Change in Inventory over the past three periods came in at $123000.0, -$10000.0, and -$33000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.